Charles Cashion's Net Worth
$4.55 Thousand
Who is Charles Cashion?
Charles Cashion does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NovaBay Pharmaceuticals, Inc., and Conatus Pharmaceuticals Inc.
SEC CIK
Charles Cashion's CIK is 0001410079
Past Insider Trading and Trends
2009 was Charles Cashion's most active year for acquiring shares with 13 total transactions. Charles Cashion's most active month to acquire stocks was the month of December. 2009 saw Charles Cashion paying a total of $1,900.00 for 27,505 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NovaBay Pharmaceuticals, Inc. (NBY) Snapshot price: $0.1331
InvestorCharles Cashion owns 48,469 units of Common Stock which is worth $6,451.22. From 2007 to 2015 Charles Cashion acquired a total of 37,987 shares in NovaBay Pharmaceuticals, Inc. at a cost of $1,900.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4/A
| +80.33% | 8.24K |
—
|
—
| 18.5K |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +4.79% | 1.35K |
—
|
—
| 29.52K |
Sep 14
| |||
Form 4
| +3.68% | 1K |
$1.90 | $1,900.00 | 28.17K |
Aug 31
| |||
Form 4
| +5.55% | 1.43K |
—
|
—
| 27.17K |
Aug 28
| |||
Form 4
| +2.00% | 504 |
—
|
—
| 25.74K |
Aug 13
| |||
Form 4
| +4.64% | 1.12K |
—
|
—
| 25.24K |
Jun 4
| |||
Form 4
| +1.96% | 463 |
—
|
—
| 24.12K |
May 14
| |||
Form 4
| +2.22% | 513 |
—
|
—
| 23.66K |
May 7
| |||
Form 4
| +2.08% | 472 |
—
|
—
| 23.14K |
Mar 30
| |||
Form 4
| +6.37% | 1.36K |
—
|
—
| 22.67K |
Mar 26
| |||
Form 4
| +3.53% | 727 |
—
|
—
| 21.32K |
Mar 19
| |||
Form 4
| +11.32% | 2.09K |
—
|
—
| 20.59K |
Mar 10
| |||
Form 4
| +80.33% | 8.24K |
—
|
—
| 18.5K |
Jan 14
| |||
Form 4
| +6.21% | 600 |
—
|
—
| 10.26K |
Nov 5
| |||
Form 4
| +16.30% | 1.35K |
—
|
—
| 9.66K |
Aug 25
| |||
Form 4
| +7.59% | 586 |
—
|
—
| 8.3K |
Aug 8
| |||
Form 4
| +19.16% | 1.24K |
—
|
—
| 7.72K |
Jun 5
| |||
Form 4
| +8.68% | 517 |
—
|
—
| 6.48K |
May 9
| |||
Form 4
| +25.64% | 1.22K |
—
|
—
| 5.96K |
Apr 16
| |||
Form 4
| +27.23% | 1.01K |
—
|
—
| 4.74K |
Mar 6
| |||
Form 4
| +59.25% | 1.39K |
—
|
—
| 3.73K |
Feb 29
| |||
Form 4
| +75.49% | 1.01K |
—
|
—
| 2.34K |
Jan 14
| |||
Form 4
| +75.76% | 575 |
—
|
—
| 1.33K |
Dec 14
| |||
Form 4
| +235.84% | 533 |
—
|
—
| 759 |
Nov 14
| |||
Form 4/A
|
∞
| 226 |
—
|
—
| 226 |
Nov 5
| |||
Form 4
|
∞
| 226 |
—
|
—
| 226 |
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Conatus Pharmaceuticals Inc (HSTO) Snapshot price: $0.34
SVP, Finance, CFO and Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||